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H quire certain factors for viability and will die in the absence of these fa~tors.l-~ The death of the cells is caused by apoptosis,6-8 also referred to as programmed cell death, which occurs during development of different cell type^.^-^^ Apoptosis can also be induced by various cytotoxic treatments in different cell types.9 Using myeloid cells as a model system to study regulation of cell viability, growth, and differentiati~n,*J*-'~ we have shown that some hematopoietic cytokines can inhibit transforming growth factor (TGF) pl-induced cell death in normal myeloid precurs o r~.~~ Induction of cell death in cancer cells by apoptosis, or by a mechanism such as necrosis, and inhibition of this cell death are obviously of importance in cancer therapy. We have now determined the ability of TGF-p1 and other cytotoxic or growth inhibitory compounds to induce apoptotic cell death in myeloid leukemic cells and the ability of hematopoietic cytokines to prevent this induction of apoptosis. We show that TGF-PI can induce apoptosis in myeloid leukemic cells, that certain cytokines can inhibit the induction of apoptosis induced by TGF-PI, and that these cytokines can also inhibit apoptosis induced by a variety of cytotoxic compounds, some of which are used in cancer chemotherapy. 
MATERIALS AND METHODS
Cells and cell culture. Two clones of myeloid leukemic cells were used. Clone 31h was obtained from a spontaneous myeloid leukemia in an SL mouse (M1 leukemia)" and clone 7-MI2 from a myeloid leukemia obtained after x-irradiation in an SJL/J mouse.I8
Both clones are cytokine-independent for viability and multiplicatied and were cultured at 37°C in Dulbecco's modified Eagle's medium (DMEM, H-21 GIBCO, Grand Island, NY) and 10% inactivated (56"C, 30 minutes) horse serum (GIBCO).
Pure recombinant mouse interleukin (IL)-6l9 was obtained from Dr J. Van Snick; pure recombinant human granulocyte colony-stimulating factor (G-CSF),20 pure recombinant mouse stem cell factor (SCF)2' and pure recombinant mouse granulocyte-macrophage (GM)-CSF2* from Dr S. Gillis; pure recombinant human IL-la23 from Dr P. Lomedico; and pure recombinant mouse IL-324 from Dr P.
Vassalli. Conditioned medium from L929 fibroblasts was used as a source of macrophage (M)-CSF. Human TGF-PI was purchased from British Bio-technology Ltd, Oxford, UK; vincristine from Teva Pharmaceutical Industries, Jerusalem, Israel; adriamycine from Farmitalia Carlo Erba, Italy; cytosine arabinoside, cycloheximide, and mouse interferon ci/p from Sigma Chemical Co, St Louis, MO; sodium azide from Merck, Darmstadt, Germany; and cyclosporine A from Sandoz Ltd, Basel, Switzerland.
Cells were seeded at 3 x 10S/mL and cultured without, or with different, compounds. Viable and dead cells were determined by counting the number of trypan blue-excluding and stained cells, respectively, in a hemocytometer. The percentage of apoptotic cells was determined on May-Griinwald Giemsa stained cytospin preparations (ShandonElliot cytocentrifuge, Astmoor, UK) by counting 400 cells. Apoptotic cells were small and with fragmented nuclei and condensed chromatin compared with the intact larger cells with a large defined nucleus. DNA fragmentation in cells undergoing apoptosis was assayed as described previously.8 Cells (2 x lo6) were lysed in 0.4 mL lysis buffer containing 200 mmol/L Tris-HCL, pH 8.0; 100 mmol/L EDTA, 1% sodium dodecyl sulfate (SDS), and 50 pg/mL proteinase K (Merck). After 4 hours at 37°C the DNA was extracted with an equal volume of water-saturated phenol/ chloroform followed by chloroformiisoamyl alcohol (24:1), the aqueous phase was collected, and DNA was precipitated by adding NaCl to 150 mmol/L and 2 vol ethanol at -20°C overnight. The DNA pellet was dried under vacuum and resuspended in 0.4 mL 10 mmol/L Tris, 10 mmol/L NaCI, and 1 mmol/L EDTA (TNE buffer). RNAse A (50 pg/mL) was added for 5 hours followed by proteinase K (120 pg); after 5 hours of incubation, the DNA was 
RESULTS

Sfurisricul analysis.
Inhibition of TGF-PI induced apoptosis by hematopoietic cytokines. Incubation of M1 clone 3 myeloid leukemic cells for 1 day in culture with 2 ng/mL TGF-P1 has shown that the number of viable cells (excluding trypan blue) increased almost as in cultures without TGF-P1 and the percent viability decreased only slightly from 99% 2 1% to 83% 2 2% (Fig 1) . After 2 days with TGF-PI there was no further increase in the number of viable cells but the percent viability had decreased to 52% 2 6% with a further decrease to 21% 2 3% after 3 days (Fig 1) . After 2 days in culture with TGF-P1, about 7% 2 2% of the cells had a typical apoptotic morphology with a fragmented nucleus and condensed chromatin (Fig 2) . The DNA of these TGF-p1-treated cells showed a ''ladder'' of DNA fragments (Fig 3) caused by internucleosomal cleavage of DNA typical of apoptotic cell death.= In addition to these apoptotic cells there were nonviable cells in the TGF-PItreated cultures that did not have a defined nuclear or cytoplasmic structure and stained with trypan blue. After 3 days with TGF-P1, the cultures contained 10% 2 2% apoptotic cells and 79% 5 4% trypan blue stained nonviable cells. These data suggest that, after acquiring apoptotic features, the cells rapidly disintegrated losing recognizable cellular morphology so that accumulation of a large proportion of cells that could be recognized as apoptotic did not occur. Addition of 10 ng/mL G-CSF together with TGF-PI maintained the viability of the cells at 99% and the cells multiplied to the same level as in cultures without TGF-PI (Fig 1, Table 1) . This indicates that G-CSF inhibited the effect of TGF-P1 on viability and growth. The results with IL-6 were similar to those obtained with G-CSF (Table 1) . G-CSF and IL-6 also inhibited TGF-pl-induced DNA fragmentation (Fig 3) and the formation of apoptotic cells (Fig 2) . The faint bands of fragmented DNA from cells cultured with TGF-PI and IL-6, or TGF-P1 and G-CSF (Fig 3, lanes 3 and 4) suggests the existence of a low frequency of cells with DNA degradation in these cultures, which was much lower than in cultures with TGF-PI alone (Fig 3, lane 2) . Results with other hematopoietic cytokines have shown that IL-la partially inhibited the effect of TGF-P1 on viability and on the increase in the number of cells, IL-3, and SCF were less effective, and GM-CSF and M-CSF were not effective (Table 1) .
Similar experiments performed with cells derived from a different myeloid leukemia (7-M12) also showed that the inhibitory effect of TGF-PI on cell viability and growth was inhibited by hematopoietic cytokines although, in these cells, GM-CSF and IL-3 were effective, whereas IL-6, G-CSF or the other hematopoietic cytokines tested were not ( that various hematopoietic cytokines can inhibit thc induction of apoptotic ccll death by TGF-PI and that thcir cffectivcncss varics depending on the lcukemic cclls.
Efect of hematopoietic cytokines on apoptosis and growth inhibition by chemotherapeutic agents. The inhibition by various cytokines of TGF-pl-induced apoptotic death in thc lcukemiccclls, and thc inhibition of apoptosis by IL-6 in MI cells engineered to cxpress the tumor supprcssing wild type p53 promptcd us to test whethcr thcsc cytokines could also inhibit the effect of othcr cytotoxic or growth inhibitory compounds, somc of which arc currcntly used in canccr chcmothcrapy. We tested vincristine, vinblastine, adriamycinc, cytosinc arabinoside, cycloheximidc, sodium azide, cyclosporinc A, and interferon a / p that affcct the viability or multiplication of cells by different mcchanisms. Rcsults with thc microtubule-disrupting compound vincristinc indicate that, like TGF-PI, its ability to rcduce thc viability of leukemic cclls (Fig 4) was associatcd with apoptosis (Tablc 2). Vinblastine gave similar rcsults (data not shown). Both G-CSF and IL-6 inhibitcd this vincristincinduccd apoptotic ccll dcath in M1 cclls (Fig 4, Tablc 2 ) and GM-CSF inhibited this ccll dcath in 7-M12 cclls (Tablc 2). Howcvcr, unlikc TGF-P1, thcsc cytokincs did not restore ccll multiplication in thc prcsencc of vincristine so that the culturcs still showed the same pcrccntage of mctaphasc-arrested cclls and the numbcr of viablc cclls did not incrcasc abovc the seeding lcvel (30 x 104 cells/mL) (Fig 4, Tablc 2) .
The sensitivity of 7-MI2 cclls to the cytotoxic action of 15 ng/mL of vincristinc was higher than in MI cells trcatcd with 70 ng/mL of vincristinc (Tablc 2). Thcrcforc, wc dctcrmincd the kinetics of appcarancc of apoptotic cclls in the morc scnsitivc 7-M12 cclls trcatcd with othcr cytotoxic agcnts. Addition of adriamycine, cytosine arabinosidc. cycloheximidc, and sodium azidc induccd a high proportion of apoptotic cells aftcr a fcw hours in culturc (Fig 5) . bcfore ccll disintegration occurrcd. With cyclohcximidc-trcatcd 7-M12 cclls thcrc wcrc about 50% apoptotic cclls (Fig 5) and no trypan blue staincd cclls aftcr 4 hours. Howcvcr, at 24 hours only 2% to 5% apoptotic cclls rcmaincd and 85% to 90% of thc cclls staincd with trypan bluc. As cxpccted, thc apoptotic statc is, thercforc, transient and is followed by ccll dcath and disintegration. Thc induction of apoptosis in 7-MI2 cclls trcatcd with cytotoxic agcnts was also associatcd with DNA fragmentation (Fig 6) . GM-CSF inhibited thc induction of apoptosis in 7-MI2 cclls by all thcsc compounds (Fig 5) . M1 cclls treated with thcse compounds showcd only a low frcqucncy of apoptotic cclls (Icss than 4% aftcr 10 hours). GM-CSF addcd to cclls trcatcd with these cytotoxic compounds incrcascd the percentage of viable 7-MI2 cells (excluding trypan bluc) (P < .001) (Tablc 3). A similar but smallcr cffcct was found with G-CSF and IL-6 on MI cclls trcatcd with cytosine arabinoside (P < .05), cycloheximide (P < .()I), or sodium azide (P < .02) ( Table 3) . As with vincristinc, thc addition of thcsc cytokincs to M1 cultured with cycloheximide or sodium azidc, and to 7-MI2 cultured with cytosine arabinoside, did not incrcasc thc number of viablc cells abovc the seeding lcvcl (30 x lo4 cclls/mL) (Tablc 3). Howcvcr, G-CSF or IL-6 incrcascd above the seeding lcvcl thc number of viablc MI cells cultured with adriamycine (P < .W2) or cytosine arabinoside (P < .02) and GM-CSF increased the number of viable 7-MI2 cells cultured with adriamycine (P < .001), cycloheximide (P < .001), or sodium azide (P < .001) ( Table 3 ). This indicates that these cytokines can also induce cell multiplication in the presence of some cytotoxic compounds. Unlike the effect of cytokines on cell multiplication in the presence of TGF-PI, the increase in the number of viable cells induced by G-CSF, IL-6, or GM-CSF in the presence of these cytotoxic agents was lower than in cultures without these compounds (P < .W1) (Table 3) .
Two other compounds, interferon alp and cyclosporine A, inhibited cell multiplication of M1 cells without reducing their viability and with no evidence of apoptosis, and neither of these compounds inhibited cell viability or multiplication of 7-MI2 cells ( Table 4) . G-CSF and IL-6 partially protected MI cells from the growth inhibitory effect of cyclosporine A (P < . 0 1 ) but did not protect them from growth inhibition induced by interferon alp ( Table 4) .
The results indicate that G-CSF, IL-6, and GM-CSF can inhibit apoptotic cell death in clones of myeloid leukemic cells treated with a variety of cytotoxic compounds, some of which are used in cancer chemotherapy. However, these 1 2 3 4 5 6 ~ ~~ *M1 clone 3 and 7-M12 cells were seeded at 30 x 104/mL and adriamycine, cytosine arabinoside, cycloheximide, or sodium azide were added at tThe cells were cultured without (None) or with 10 ng/mL G-CSF or IL-6 and 5 ng/mL GM-CSF.
the indicated concentrations.
cytokines had either no effect or only partially protected against the growth inhibitory effect induced by some of these compounds.
DISCUSSION
Cell death by apoptosis is the major mode of naturally occurring cell death in a variety of biologic systems, including hematopoietic and nonhematopoietic tissues, and occurs also in growing tumors and regressing tumors after chemotherapy.y The present experiments using two clones of myeloid leukemic cells derived from two different leukemias have shown that TGF-P1, as well as the cytotoxic agents vincristine, vinblastine, adriamycine, cytosine arabinoside, cycloheximide, and sodium azide, induced cell death by apoptosis. Results with the U-937 and HL-60 myeloid leukemic cell lines treated with cytosine arabinosidez7 and a derivative of adriamy~ine?~ respectively, chronic lymphocytic leukemia cells treated with cyclohe~imide,~~ and Burkitt's lymphoma cells treated with nitrogen mustard,30 also showed induction of apoptotic cell death. Therefore, apoptotic cell death can be induced by a variety of compounds whose primary action may affect different cellular structural components and functions. Inhibition of protein synthesis by cycloheximide can decrease apoptosis in certain cellsy but can also induce apoptosis as found in the present and otherz9 experiments.
Different types of factor-dependent cells, including myeloid cells, undergo programmed cell death by apoptosis following withdrawal of the required viability f a c t~r .~-~,~~ Our present results show that certain hematopoietic cytokines can inhibit apoptotic death induced by TGF-P1 and by various cytotoxic compounds in leukemic cells that are not inherently factor-dependent for viability and growth. The ability of GM-CSF, IL-3, and IL-6 and the inability of use only.
For personal at PENN STATE UNIVERSITY on February 23, 2013. bloodjournal.hematologylibrary.org From M-CSF to protect cells from apoptosis in the two myeloid leukemias used in the present experiments, correlated with the presence or absence of receptors for these cytokines on the leukemic cel1s.j However, although both leukemias had receptors for G-CSF,32 only the M1, but not the 7-M12 leukemia, was protected from apoptosis by G-CSF. The addition of cytokines to the leukemic cells used in the present experiments induces the expression of several transcription factors.33 This induction of transcription factors may play a role in protection by the cytokines from the induction of apoptosis by TGF-P1 and the cytotoxic agents.
Unlike their ability to induce cell multiplication of factor-dependent cells or TGF-pl-treated cells, the cytokines did not counteract the metaphase arrest induced by vincristine or vinblastine and had either no effect or only partially protected against inhibition of cell multiplication induced by various cytotoxic compounds. Therefore, inhibition of apoptotic cell death by these cytokines can be regulated independently from the ability of the cytokines to induce cell multiplication. The ability of G-CSF or IL-6 to decrease the growth inhibitory effect of cyclosporine A but not of interferon (YIP, both of which did not induce apoptosis, indicates that there are different mechanisms by which inhibition of cell multiplication was induced by these two compounds. The two clones of factor-independent myeloid leukemic cells used in the present experiments differed in their sensitivity to induction of apoptosis by different cytotoxic agents. Expression of the bcl-2 gene can induce resistance to a p o p t o~i s . 3~,~~ It is of interest that the difference in sensitivity of the two clones to induction of apoptosis by cytotoxic agents was associated with a difference in the expression of bcl-2 (Lotem and Sachs, to be published).
It has been suggested from experiments performed by others using myeloid leukemic cells from AML or CML patients that cytokines such as GM-CSF or IL-3 could enhance the cytotoxicity of cytosine arabinoside or adriamycine.36,37 These experiments were performed using the ability of cells to form colonies in culture in the presence of GM-CSF or IL-3 as a measure of viability. However, this method does not distinguish between cell toxicity and inhibition of cell growth, both of which lead to a decrease in colony formation. Without these cytokines, cells from most patients did not form any colonies in agar and were mostly noncycling, and the cytokines increased the frequency of cycling ~e l l s .~~,~~ Therefore, unlike our experiments, these studies did not compare the effect of the cytokines on toxicity induced by cytotoxic agents on cycling cells, but reflect the differential effect of cytotoxic agents on cycling versus noncycling cells. Furthermore, other experiments have shown that GM-CSF and IL-3 can protect cycling factor-dependent human colony-forming leukemic cells from the toxicity induced by cytosine arabinoside when compared with leukemic cells cultured with G-CSF.3s Because factor-dependent leukemic cells die in the absence of factors, we suggest that the suppression of production of cytokines coupled with cytotoxic treatment may result in better killing of the leukemic cells.
The present results can have important implications for the use of hematopoietic cytokines to ameliorate myelosuppression following the use of radiation or chemotherapeutic agents in cancer therapy.13J4,39%40 The use of cytokines such as G-CSF,41-44 GM-CSF,45,46 or IL-647,48 may not only stimulate the recovery of normal hematopoietic cells but may also enhance the viability of leukemic cells that have functional receptors for these cytokines in the treated patients. This may also apply to other types of tumor cells (nonhematopoietic) that have receptors for these cytokines. Therefore, we suggest that treatment of cancer patients with therapeutic agents and with these cytokines should be carefully timed so as to avoid protection of cancer cells from the cytotoxic action of these compounds. 
